Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Journal of Rheumatology
|
November 3, 2019
Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence
Katherine A Yates, Kazuki Yoshida, Chang Xu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 7, 2020
Reply
Vibeke Norvang, Tore K Kvien, Till Uhlig, et al.
The Journal of Rheumatology
|
February 17, 2016
Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
Till Uhlig, Elisabeth Lie, Vibeke Norvang, et al.
BMC Medical Research Methodology
|
June 1, 2022
Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data
Vibeke Norvang, Espen A Haavardsholm, Sara K Tedeschi, et al.
RMD Open
|
November 30, 2018
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
Vibeke Norvang, Joseph Sexton, Eirik K Kristianslund, et al.
BMJ (Clinical Research Ed.)
|
April 18, 2023
Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study
Houchen Lyu, Sizheng Steven Zhao, Licheng Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2020
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies
Vibeke Norvang, Gina H Brinkmann, Kazuki Yoshida, et al.
Seminars in Arthritis and Rheumatism
|
September 13, 2018
Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study
Gina Hetland Brinkmann, Vibeke Norvang, Ellen Sauar Norli, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Journal of Rheumatology
|
November 3, 2019
Acute Calcium Pyrophosphate Crystal Arthritis Flare Rate and Risk Factors for Recurrence
Katherine A Yates, Kazuki Yoshida, Chang Xu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 7, 2020
Reply
Vibeke Norvang, Tore K Kvien, Till Uhlig, et al.
The Journal of Rheumatology
|
February 17, 2016
Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study
Till Uhlig, Elisabeth Lie, Vibeke Norvang, et al.
BMC Medical Research Methodology
|
June 1, 2022
Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data
Vibeke Norvang, Espen A Haavardsholm, Sara K Tedeschi, et al.
RMD Open
|
November 30, 2018
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
Vibeke Norvang, Joseph Sexton, Eirik K Kristianslund, et al.
BMJ (Clinical Research Ed.)
|
April 18, 2023
Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study
Houchen Lyu, Sizheng Steven Zhao, Licheng Zhang, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 25, 2020
Achievement of remission in two early rheumatoid arthritis cohorts implementing different treat-to-target strategies
Vibeke Norvang, Gina H Brinkmann, Kazuki Yoshida, et al.
Seminars in Arthritis and Rheumatism
|
September 13, 2018
Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study
Gina Hetland Brinkmann, Vibeke Norvang, Ellen Sauar Norli, et al.
Page
of 1